| Authors: |
de Jonge L; Department of Public Health, Erasmus MC University Medical Center, Rotterdam, the Netherlands. Electronic address: l.dejonge.3@erasmusmc.nl., Lansdorp-Vogelaar I; Department of Public Health, Erasmus MC University Medical Center, Rotterdam, the Netherlands., Doria-Rose VP; Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA., Portillo I; Screening Programmes, The Basque Health Service, Spain., Novak Mlakar D; National Institute for Public Health, Ljubljana, Slovenia., Buron A; Epidemiology and Evaluation Research Group, Hospital del Mar Institute, Barcelona, Catalunya, Spain; Health Services Research on Chronic Patients Network, REDISSEC, Madrid, Spain., Quintin C; Santé Publique France, Saint-Maurice, France., Espinàs JA; Catalonian Cancer Strategy, Department of Health, Government of Catalonia, Barcelona, Spain., Plaine J; Santé Publique France, Saint-Maurice, France., Škrjanec AL; National Institute for Public Health, Ljubljana, Slovenia., Kofol Bric T; National Institute for Public Health, Ljubljana, Slovenia., Binefa G; Cancer Screening Unit, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Spain., Font R; Cancer Screening Unit, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Spain., Bulliard JL; Center for Primary Care and Public Health (Unisanté), Lausanne, Switzerland., Chubak J; Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA., Ziebell R; Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA., McCurdy BR; Cancer Screening, Primary and Community-Based Care, Ontario Health, Ontario, Canada., Rabeneck L; ICES, Toronto, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Senore C; Epidemiology and Screening Unit - CPO, University Hospital Città della Salute e della Scienza, Turin, Italy. |
